There are 2789 resources available
908P - Efficacy and safety of penpulimab plus anlotinib in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): A phase II study
Presenter: Yuan-Kai Shi
Session: ePoster Display
910P - Repurposing pantoprazole in advanced head and neck squamous cell carcinoma: A phase I/II randomized study
Presenter: Vanita Noronha
Session: ePoster Display
912P - Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
Presenter: Viktor Gruenwald
Session: ePoster Display
913P - Apatinib for heavily pretreated recurrent and/or metastatic head and neck squamous cell carcinoma: Updated analysis
Presenter: kunyu yang
Session: ePoster Display
914P - Impact of induction chemotherapy (ICT) in borderline resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC)
Presenter: Divya Kukreja
Session: ePoster Display
851P - Treatment efficacy for adults with relapsed or refractory acute lymphoblastic leukemia: A systematic literature review (SLR)
Presenter: Yun Liu
Session: ePoster Display
852P - Feasibility and safety of HiDAC in AML patients who have achieved CR with hypomethylating agents: Prospective study
Presenter: Sanjo Varghese
Session: ePoster Display
Resources:
Abstract
917P - Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial
Presenter: Anna Finger
Session: ePoster Display